Shilpa Katta

机构：Leidos (United States), Frederick National Laboratory for Cancer Research, National Cancer Institute, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc. (United States)

发表论文 41 篇 · 总被引 482 次 · h-index 11

代表论文

• Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights (2023 · European Urology · 被引 75)
• Telomere length and epigenetic clocks as markers of cellular aging: a comparative study (2022 · GeroScience · 被引 61)
• Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells (2019 · International Journal of Molecular Sciences · 被引 38)
• Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells (2017 · Molecular Cancer Research · 被引 38)
• DNA-methylation-based telomere length estimator: comparisons with measurements from flow FISH and qPCR (2021 · Aging · 被引 36)
• Transcriptomics of Long-Term Meditation Practice: Evidence for Prevention or Reversal of Stress Effects Harmful to Health (2021 · Medicina · 被引 16)